Sid Sehgal

Sid Sehgal is an accomplished executive with extensive experience in the pharmaceutical and healthcare sectors, currently serving as Executive Director and Product Strategy Lead for Early Breast Cancer at Novartis since July 2023. Prior to this role, Sid co-founded Helix Strategy LLC in April 2018, a management consulting firm focused on life sciences and healthcare. Sid's previous positions include Executive Director of Immunology Commercial Strategy at Mallinckrodt Pharmaceuticals and various leadership roles at Allergan, where responsibilities spanned product management and commercial strategies across multiple therapeutic areas. Sid holds a BA in Biology from the University of Pennsylvania and an MBA in Marketing and International Business from NYU Stern School of Business.